Trinity Biotech PLC (NAS:TRIB)
$ 1.69 0.06 (3.68%) Market Cap: 16.00 Mil Enterprise Value: 79.73 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 56/100

Q4 2023 Trinity Biotech PLC Earnings Call Transcript

Apr 04, 2024 / 12:00PM GMT
Release Date Price: $2 (-1.39%)
Operator

Greetings. Welcome to Trinity Biotech's fourth quarter and full-year 2023 earnings conference call. (Operator Instructions) Please note that this conference is being recorded.

At this time, we'll now turn the conference over to Eric Ribner with Investor Relations. Eric, you may now begin.

Eric Ribner
LifeSci Advisors, LLC - IR

Good morning, everyone, and thank you for joining us on today's call.

Before we begin, please note that statements made during this presentation may be deemed forward-looking statements within the meaning of federal securities laws. These statements are subject to known and unknown risks and uncertainties that may cause actual events to differ from those expressed or implied in such statements. These risks include but are not limited to those set forth in the risk factor statement in the company's annual report on Form 20-F filed with the Securities and Exchange Commission. Trinity Biotech undertakes no obligation to publicly advise, update, or revise these forward-looking statements to reflect events or circumstances

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot